Michel Liévre

2.3k total citations
19 papers, 459 citations indexed

About

Michel Liévre is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michel Liévre has authored 19 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michel Liévre's work include Coronary Interventions and Diagnostics (5 papers), Health, Medicine and Society (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Michel Liévre is often cited by papers focused on Coronary Interventions and Diagnostics (5 papers), Health, Medicine and Society (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Michel Liévre collaborates with scholars based in France, United States and Canada. Michel Liévre's co-authors include H Milon, Christine Mestre, A Gressard, Pierre Lantelme, Olivier Bastien, Jean François Obadia, Régine Sitruk‐Ware, Jean‐Pierre Boissel, Michel Cucherat and I. Pélissou-Guyotat and has published in prestigious journals such as Hypertension, Journal of Clinical Epidemiology and Neurosurgery.

In The Last Decade

Michel Liévre

16 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Liévre France 7 383 93 68 57 41 19 459
Kiyomichi Yoshimaru Japan 8 271 0.7× 70 0.8× 24 0.4× 47 0.8× 65 1.6× 17 323
Martin Stockburger Germany 16 630 1.6× 113 1.2× 35 0.5× 24 0.4× 19 0.5× 62 680
Ronald Hödl Austria 8 261 0.7× 88 0.9× 12 0.2× 27 0.5× 43 1.0× 21 325
Alexander R. Cale United Kingdom 12 144 0.4× 180 1.9× 41 0.6× 97 1.7× 17 0.4× 32 313
Murat Özdemir Türkiye 10 220 0.6× 94 1.0× 26 0.4× 53 0.9× 55 1.3× 32 280
Syed Yaseen Naqvi United States 9 237 0.6× 110 1.2× 27 0.4× 83 1.5× 44 1.1× 37 332
Alessandra Magini Italy 10 265 0.7× 49 0.5× 48 0.7× 106 1.9× 114 2.8× 20 378
Evelyne Goudreau United States 10 281 0.7× 220 2.4× 35 0.5× 59 1.0× 104 2.5× 33 383
Irma Battipaglia Italy 13 357 0.9× 106 1.1× 21 0.3× 32 0.6× 85 2.1× 30 445
Lana Tsao United States 9 259 0.7× 147 1.6× 80 1.2× 38 0.7× 10 0.2× 22 424

Countries citing papers authored by Michel Liévre

Since Specialization
Citations

This map shows the geographic impact of Michel Liévre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Liévre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Liévre more than expected).

Fields of papers citing papers by Michel Liévre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Liévre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Liévre. The network helps show where Michel Liévre may publish in the future.

Co-authorship network of co-authors of Michel Liévre

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Liévre. A scholar is included among the top collaborators of Michel Liévre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Liévre. Michel Liévre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cariou, Bertrand, Michel Liévre, D. Huet, et al.. (2013). O10 Fréquence des hypoglycémies chez 4 424 diabétiques insulino-traités en France : résultats du suivi observationnel prospectif de l’étude DIALOG. Diabetes & Metabolism. 39. A3–A3. 1 indexed citations
2.
Gouet, D., É. Eschwège, Alfred Penfornis, et al.. (2013). PO45 Facteurs prédictifs des hypoglycémies chez les diabétiques de type 1 et de type 2 insulino-traités en France : Analyse de l’étude DIALOG. Diabetes & Metabolism. 39. A31–A31.
3.
Liévre, Michel, et al.. (2012). EP-1272 MEDICO-ECONOMICAL PROSPECTIVE RANDOMIZED TRIALS OF CARBON IONS THERAPY. Radiotherapy and Oncology. 103. S485–S485. 1 indexed citations
4.
Cohen, Salomon‐Yves, Eric H. Souied, Michel Weber, et al.. (2010). Patient characteristics and treatment of neovascular age-related macular degeneration in France: the LUEUR1 observational study. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(4). 521–527. 6 indexed citations
5.
Liévre, Michel & Régine Sitruk‐Ware. (2009). Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. Contraception. 80(1). 95–100. 12 indexed citations
6.
Boissel, Jean‐Pierre, Michel Cucherat, Patrice Nony, et al.. (2007). New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear. Journal of Clinical Epidemiology. 61(3). 301–307. 14 indexed citations
7.
Robert, Roger, Gilles Rioufol, Gérard Finet, et al.. (2004). Experimental assessment of new stent technologies: Validation of a comparative paired rabbit iliac artery study model. Journal of Biomedical Materials Research Part B Applied Biomaterials. 70B(2). 303–310. 2 indexed citations
8.
Villar, Emmanuel, Michel Liévre, M Labeeuw, & Claire Pouteil‐Noble. (2003). [The NEPHRODIAB2 randomized trial].. PubMed. 24(6). 317–9. 1 indexed citations
9.
Liévre, Michel. (2003). [Biases in clinical research].. PubMed. 53(19). 2096–8. 1 indexed citations
10.
Lantelme, Pierre, Christine Mestre, Michel Liévre, A Gressard, & H Milon. (2002). Heart Rate. Hypertension. 39(6). 1083–1087. 286 indexed citations
11.
Cucherat, Michel, Michel Liévre, & François Gueyffier. (2000). [Clinical benefits of cholesterol lowering treatments. Meta-analysis of randomized therapeutic trials].. PubMed. 29(17). 965–76. 7 indexed citations
12.
Liévre, Michel, et al.. (1997). Validation of a new quantitative coronary angiography analysis system used to evaluate densitometric lumen remodelling. International journal of cardiac imaging. 13(1). 15–22. 3 indexed citations
13.
Obadia, Jean François, et al.. (1997). Outcome of atrial fibrillation after mitral valve repair. Journal of Thoracic and Cardiovascular Surgery. 114(2). 179–185. 104 indexed citations
14.
Boissel, J P, E Autret, P Bechtel, et al.. (1997). [Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie].. PubMed. 51(6). 655–66. 1 indexed citations
15.
Rosenberg, Yves, Michel Liévre, P. Chirossel, & J. P. Boissel. (1994). Can change in coronary lumen volume be used as a more sensitive end-point in clinical trials of prevention of restenosis after coronary angioplasty? The PRESANCE study. Atherosclerosis. 109(1-2). 157–157. 1 indexed citations
16.
Liévre, Michel & Jean‐Pierre Boissel. (1993). [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].. PubMed. 86 Spec No 4. 91–8. 5 indexed citations
17.
Pélissou-Guyotat, I., et al.. (1991). Inhibition of subintimal hyperplasia of autologous vein bypass grafts by nimodipine in rats. Neurosurgery. 29(6). 850–850. 8 indexed citations
18.
Pélissou-Guyotat, I., et al.. (1991). Effect of Nimodipine on Subintimal Hyperplasia of Autologous Vein Bypass Grafts in Rats. Journal of Cardiovascular Pharmacology. 17(5). 778–785. 5 indexed citations
19.
Descotes, J, et al.. (1978). Effets électrophysiologiques cardiaques du gluconate de lithium chez le chien anesthésié.. Therapies. 33(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyomichi Yoshimaru Breakdown of academic impact, for papers by Martin Stockburger Breakdown of academic impact, for papers by Ronald Hödl Breakdown of academic impact, for papers by Alexander R. Cale Breakdown of academic impact, for papers by Murat Özdemir Breakdown of academic impact, for papers by Syed Yaseen Naqvi Breakdown of academic impact, for papers by Alessandra Magini Breakdown of academic impact, for papers by Evelyne Goudreau Breakdown of academic impact, for papers by Irma Battipaglia Breakdown of academic impact, for papers by Lana Tsao
Rankless by CCL
2026